SteroTherapeutics is a privately held pharmaceutical company focused on developing novel therapies for diseases with significant unmet needs. SteroTherapeutics is pursuing a novel drug therapy for major diseases related to metabolic syndrome, which afflicts 35% of the US adult population. Our lead molecule, Fluasteroneis a non-androgenic analogue of dehydroepiandrosterone (DHEA). Fluasterone is a selective anti-glucocorticoid ...
SteroTherapeutics is a privately held pharmaceutical company focused on developing novel therapies for diseases with significant unmet needs. SteroTherapeutics is pursuing a novel drug therapy for major diseases related to metabolic syndrome, which afflicts 35% of the US adult population. Our lead molecule, Fluasteroneis a non-androgenic analogue of dehydroepiandrosterone (DHEA). Fluasterone is a selective anti-glucocorticoid which suppresses many of glucocorticoid deleterious effects but does not antagonize its anti-inflammatory activity. This unique mechanism of action makes it a suitable molecule for managing in which excess exposure.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.